IDO1 inhibition has shown to increase the therapeutic efficacy of checkpoint inhibitors, cancer vaccines, or even chemotherapy (34, 50–52) in mice and human tumors grafted into immunodeficient mice reconstituted with human lymphocytes (53). This evidence concerns the gene IDO1 and cancer.